Tandem Diabetes Care Inc (NASDAQ:TNDM)’s traded shares stood at 1.08 million during the last session, with the company’s beta value hitting 1.34. At the close of trading, the stock’s price was $31.35, to imply a decrease of -1.29% or -$0.41 in intraday trading. The TNDM share’s 52-week high remains $53.69, putting it -71.26% down since that peak but still an impressive 55.92% since price per share fell to its 52-week low of $13.82. The company has a valuation of $2.05B, with an average of 1.29 million shares in intraday trading volume over the past 10 days and average of 1.45 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Tandem Diabetes Care Inc (TNDM), translating to a mean rating of 1.77. Of 10 analyst(s) looking at the stock, 1 analyst(s) give TNDM a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 8 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.4.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Tandem Diabetes Care Inc (NASDAQ:TNDM) trade information
After registering a -1.29% downside in the last session, Tandem Diabetes Care Inc (TNDM) has traded red over the past five days. The 5-day price performance for the stock is -11.29%, and -28.88% over 30 days. With these gigs, the year-to-date price performance is 5.98%. Short interest in Tandem Diabetes Care Inc (NASDAQ:TNDM) saw shorts transact 10.07 million shares and set a 8.71 days time to cover.
The extremes give us $36 and $160 for target low and target high price respectively. As such, TNDM has been trading -410.37% off suggested target high and -14.83% from its likely low.
Tandem Diabetes Care Inc (TNDM) estimates and forecasts
Looking at statistics comparing Tandem Diabetes Care Inc share performance against respective industry, we note that the company has underperformed competitors. Tandem Diabetes Care Inc (TNDM) shares are -11.04% down over the last 6 months, with its year-to-date growth rate lower than industry average at -12.10% against 13.80%. Revenue is forecast to shrink -5.30% this quarter before jumping 29.60% for the next one. The rating firms project that company’s revenue will grow 19.20% compared to the previous financial year.
Revenue forecast for the current quarter as set by 19 analysts is 223.66M. Meanwhile, for the current quarter, a total of 19 analyst(s) estimate revenue growth to 251.63M.Earnings reports from the last fiscal year show that sales brought in 192.71M and 196.8M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 16.10% before jumping 27.90% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -6.11% for the past 5-year period. While 2024 is set for a 49.98% return in earnings, projections for the next 5 years are at 38.80% annually.
TNDM Dividends
Tandem Diabetes Care Inc has its next earnings report out on 2024-Nov-06. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Tandem Diabetes Care Inc (NASDAQ:TNDM)’s Major holders
Tandem Diabetes Care Inc insiders hold 0.75% of total outstanding shares, with institutional holders owning 120.67% of the shares at 121.58% float percentage. In total, 120.67% institutions holds shares in the company, led by BLACKROCK INC.. As of 2024-06-30, the company held over 11.12 million shares (or 17.1137% of shares), all amounting to roughly $448.14 million.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 7.38 million shares, or about 11.3518% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $297.26 million.
